Skip to main content

GlaxoSmithKline investor meeting could set up a buyable dip, Jim Cramer says

Investors should be prepared for the stock to get slammed if GlaxoSmithKline moves to cut its dividend, the "Mad Money" host said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.